Paul B Manning Taysha Gene Therapies, Inc. (TSHA) insider trading activity

Paul B Manning is of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 1.33 Million shares of TSHA, which is worth approximately $2.43 Million. The most recent transaction as insider was on Jun 27, 2024, when has been sold 1,333,333 shares (Common Stock) at a price of $2.25 per share, resulting in proceeds of $2,999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.33M

0% 3M change

18.81% 12M change

Total Value Held $2.43 Million

Paul B Manning Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 27 2024	BUY Open market or private purchase	$2,999,999 $2.25 p/Share	1,333,333 Added 50.0%	1,333,333 Common Stock
Oct 31 2022	BUY Open market or private purchase	$3,000,000 $2.0 p/Share	1,500,000 Added 47.74%	1,642,202 Common Stock
Feb 03 2022	BUY Open market or private purchase	$392,000 $7.84 p/Share	50,000 Added 26.01%	142,202 Common Stock
Feb 02 2022	BUY Open market or private purchase	$450,660 $7.77 p/Share	58,000 Added 38.61%	92,202 Common Stock
Nov 24 2021	BUY Open market or private purchase	$29,044 $13.19 p/Share	2,202 Added 6.05%	34,202 Common Stock
Nov 23 2021	BUY Open market or private purchase	$250,800 $12.54 p/Share	20,000 Added 38.46%	32,000 Common Stock
May 14 2021	BUY Open market or private purchase	$251,760 $20.98 p/Share	12,000 Added 50.0%	12,000 Common Stock

Also insider at

LQDA

Liquidia Corp Healthcare

Director

VRCA

Verrica Pharmaceuticals Inc. Healthcare

ABOS

Acumen Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

CADL

Candel Therapeutics, Inc. Healthcare

PBM

Paul B Manning

Charlottesville, VA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA

Account